Accurate assessment of splenic involvement can be of great importance for the selection of appropriate treatment for patients with lymphoma. For example, mantle radiotherapy may be the treatment of choice for patients with localized supradiaphragmatic Hodgkin's disease (HD), but is clearly inappropriate in the presence of lymphoma in the spleen. At present laparotomy with splenectomy is the only accurate method for assessing such cases. Clinical examination of the spleen is frequently an unreliable guide to the presence or absence of lymphoma. Lymphomatous infiltration may occur in normal sized spleens (Goffinet et al., 1973; Kadin et al., 1971) . Conversely, an enlarged spleen (particularly in patients with HD) does not always indicate the presence of lymphoma (Glatstein et al., 1970; Sutcliffe et al., 1976) . CT scanning, radionuclide imaging and ultrasonography can help in the assessment of splenic size and may detect the presence of focal deposits, but the overall accuracy of each of these methods for detecting splenic lymphoma is poor (Best et al., 1978; Milder et al., 1973; Silverman et al., 1972; Zornosa & Ginaldi, 1981) .
This study has been undertaken to assess the accuracy of low field strength (0.08 Tesla) magnetic resonance imaging (MRI) with spin lattice relaxation time (T1) measurement in the detection of splenic involvement by lymphoma.
Patients and methods
Volunteers and patients Seventy nine healthy volunteers were examined to assess the normal appearance of the spleen on MRI and to establish the normal range of spleen T1. Their characteristics are shown in Table I. Sixty two patients underwent MRI of the spleen. Nine patients were scanned on 2 occasions giving a total of 71 scans. The diagnosis and clinical status of these patients are shown in Table II A calculated T1 image is generated from a computed algorithm. The accuracy and reproducibility of T1 measurements using this type of imager have been previously reported (Redpath, 1982; Richards et al., 1988a Br. J. Cancer (1988), 57, 408-411 ,'. The Macmillan Press Ltd., 1988 ki..) be due to blood vessels and were excluded from the assessment of spleen T1. All other areas of high or low T1 were included in the measurements. The number of measurements made on each subject ranged from 4 to 11 (median 7). The mean spleen T1 for each subject was calculated from these values. The reproducibility of calculation of mean spleen T1 was assessed by repeating the measurements on 20 of the scans after an interval of 3 months. The maximum difference observed in the estimation of mean spleen T1 was 12msec, representing a change of 3%. In 16 of the 20 cases the difference in the 2 measurements was 5 msec or less. G these the spleen appeared grossly enlarged. In each case the spleen weighed more than 2,000g. In the other 3 cases the spleen appeared moderately enlarged on MRI. The weights for two of these were 450 g and 485 g. In the autopsy case the weight was not recorded but the spleen was described as enlarged. In T1 measurements in patients with known spleen histology (Figure 1) . Two of the 5 patients with HD in the spleen had normal spleen T, (Figure 1, column 3) . In one of these cases deposits of HD measuring up to 3 cm in diameter were found on histological examination of the spleen. Spleen T1 was below the normal range in the other 3 patients with HD in the spleen. Two of the 3 patients with low T1 had received previous chemotherapy and the other had recently undergone lymphography.
Results

Volunteers
Two of the 3 patients with histologically proven NHL in the spleen had prolonged spleen T1 (Figure 1, column 4) . In both cases the spleen was enlarged clinically and on MRI.
The third had normal spleen T1.
Histological examination of the spleen was negative for lymphoma in 11 of the 19 patients ( Figure 1 , columns 2 and 5). Nine of these had normal spleen T1. The other 2 had low spleen T1. Both of these patients had recently undergone lymphography. One had also recently completed chemotherapy. Histology of the spleen in this case showed hypocellular areas of fibrosis and the presence of fat vacuoles. Spleen T1 results from all patients (Figure 2 ). The range of spleen T1 observed from all 71 examinations was 307-469 msec. Values outside the normal range were observed on 26 occasions, 13 being above the upper limit of normal (420 msec) and 13 below the lower limit of normal (362 msec). T1 measurements for patients with definite (i.e. histologically proven), 'probable' and 'possible' splenic involvement are shown in Figure 2 . Results from scans taken during or after therapy are shown separately from those taken before treatment or at relapse. Hodgkin's disease. Two out of 15 patients with definite or probable HD in the spleen had prolonged T1 (Figure 2, column 2). Both were scanned at the time of relapse. A further 7 patients in this group had normal T1, while in the remaining 6 cases the T1 was below the normal range. Three of the patients with low values had neither received any treatment nor undergone lymphography. All 8 patients with possible (but not probable) splenic HD had normal T1 (Figure 2, column 3) . Results for the 9 patients who were scanned before and after receiving treatment are shown in Figure 3 . In each case the T1 decreased following therapy, including one patient who had only received radiotherapy to an area not involving the spleen. T1 values before and after treatment for the 8 patients who received systemic therapy were compared using a paired t test. The fall in T1 was highly significant (P<0.001).
Discussion
The results of this study are disappointing. In contrast to our findings for the liver (Richards et al., 1986) , measurement of spleen T1 by low field strength MRI is an insensitive method for detecting involvement by lymphoma. The sensitivity was particularly poor in patients with HD, for whom the diagnosis of splenic involvement is clinically most important. Normal, high and low T1 values were observed in association with definite or probable HD in the spleen.
The sensitivity of T1 measurement was somewhat better in patients with NHL. Two out of 3 patients with proven NHL in the spleen and a further 7 out of 11 patients with probable splenic lymphoma had prolonged T1. However, all 9 of these patients with abnormal T1 had splenomegaly, which in patients with NHL is itself a reasonable indicator of involvement (Goffinet et al., 1973) . T1 measurement therefore contributed little if anything to the overall assessment. In two other patients (both classified as having 'possible' involvement), prolonged spleen T1 was observed in the absence of splenomegaly. The presence of lymphoma in the spleen in one of these cases is doubtful, as spleen T1 returned to normal after the patient had been treated with radiotherapy to a distant site.
The p,oor sensitivity of T1 measurement for the detection l w l of splenic lymphoma cannot be attributed simply to a failure to detect small tumour deposits. One patient had normal T1 in the presence of large masses of HD in the spleen. Preliminary data indicate that lymphomatous node masses have T, similar to that of normal spleen (Richards, 1987a) .
If the T1 of lymphoma in the spleen is similar to that in nodes, this would explain the difficulty in detecting splenic lymphomea either by T, measurement or visually on T images.
A significant decrease in T, following therapy was observed in all patients examined before and after therapy. In some cases the post-treatment value was subnormal. While this might in part be due to successful treatment of tumour in the spleen, it could also be due to effects of chemotherapy on normal spleen T1. Spleen T1 has been reported to decrease in healthy animals exposed either to radiotherapy or to toxins (Bakker & Vriend, 1983; Ling & Foster, 1980) . The fall in T1 could be caused either by an accumulation of red blood cell debris (with a high paramagnetic iron content) or by a decrease in the water content of the spleen (Ling & Foster, 1980) . The relatively high incidence (32%) of inhomogeneity of spleen T1 in healthy volunteers was unexpected. The presence of either focal areas of abnormal T1 or of diffuse inhomogeneity on T1 images from patients should not be interpreted as evidence of pathology. The inhomogeneity of splenic T1 contrasts with the generally uniform appearance of other normal tissues on T1 images made using the same scanner (Richards et al., 1988a,b) . The anatomical basis for either the focal or the diffuse inhomogeneity found on images of the spleen in volunteers is unknown. The single case in which a large 'hot spot' was detected on one scan but not on a similar image taken 3 months later makes it unlikely that this appearance was due to a fixed anatomical structure such as a blood vessel.
Although the mean T1 of the spleen was significantly higher in females than in males the ranges of values observed in both sexes was similar. Consequently, a single normal range of T1 can be used for assessing results of splenic T1 made in patients. Spleen T1 was not affected by age. This differs from our findings for either liver or bone marrow (Richards et al., 1988a, b) .
In conclusion, splenic T1 and size measurement made by low field strength MRI are insensitive methods for detecting splenic involvement by lymphoma. In a minority of cases, however, the presence of a subnormal T1 in previously untreated patients with HD or the presence of an elevated T1 in a patient with either HD or NHL may indicate the presence of lymphoma in the spleen.
